Stock listing

Tokyo:4875 MediciNova, Inc. (メディシノバ・インク) 株価

Japanese listing (Tokyo) of MediciNova, Inc. · home listing NASDAQ:MNOV

Follow MediciNova, Inc. into a list and get an email when it puts out news.

Home listing price · NASDAQ:MNOV

$1.40 USD -0.02 (-1.4%)

Close on Oct 19, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:MNOV

Past 3 months -2.8% · daily closes, Jul 6, 2026 – Oct 19, 2026, adjusted for splits
Day range
$1.37 – $1.45 USDOct 19, 2026
Volume
144,234 sharesOct 19, 2026
Market value
$68.91M USDAt the close on Oct 19, 2026 · price × 49.22M shares outstanding
MediciNova, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:MNOV · Home$1.40 USD-0.02 (-1.4%)144,234$1.40$1.45$1.37$1.42Close on Oct 19, 2026

Daily closes

Last 3 months, Jul 20, 2026 – Oct 19, 2026 · NASDAQ:MNOV · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$1.40-0.02-1.4%$1.40$1.45$1.37144,234
$1.42-0.03-2.1%$1.47$1.499$1.4279,181
$1.45-0.02-1.4%$1.47$1.53$1.4558,655
$1.47-0.03-2.0%$1.51$1.55$1.4696,200
$1.50-0.04-2.6%$1.56$1.56$1.5034,800
$1.54+0.02+1.3%$1.49$1.58$1.48127,800
$1.52-0.02-1.3%$1.54$1.57$1.5269,900
$1.54-0.07-4.3%$1.60$1.61$1.53109,400
$1.61-0.04-2.4%$1.65$1.68$1.6078,000
$1.65-0.11-6.3%$1.72$1.72$1.65120,000
$1.76-0.02-1.1%$1.87$1.89$1.74212,900
$1.78+0.15+9.2%$1.67$1.84$1.67274,500
$1.63-0.05-3.0%$1.69$1.72$1.63263,200
$1.68-0.24-12.5%$1.86$1.86$1.66369,800
$1.92-0.18-8.6%$2.05$2.07$1.77595,100
$2.10-0.48-18.6%$2.40$2.45$1.691,617,500
$2.58-0.07-2.6%$2.68$2.69$2.53251,900
$2.65-0.15-5.4%$2.67$2.67$2.48452,800
$2.80-0.10-3.4%$2.90$3.02$2.75395,800
$2.90-0.40-12.1%$3.16$3.30$2.902,474,200
$3.30-0.02-0.6%$3.28$3.40$3.03666,900
$3.32-0.13-3.8%$3.20$3.62$2.721,634,400
$3.45+0.93+36.9%$2.84$3.90$2.837,413,200
$2.52+0.50+24.8%$2.16$2.62$2.151,420,800
$2.02+0.15+8.0%$1.94$2.07$1.93207,100
$1.87+0.06+3.3%$1.91$1.92$1.8768,500
$1.81+0.07+4.0%$1.73$1.84$1.7345,900
$1.74-0.05-2.8%$1.78$1.78$1.7267,800
$1.79+0.04+2.3%$1.82$1.85$1.75106,200
$1.75+0.12+7.4%$1.67$1.76$1.65137,800
$1.63+0.01+0.6%$1.62$1.63$1.5596,700
$1.62+0.19+13.3%$1.45$1.63$1.45111,300
$1.43-0.01-0.7%$1.44$1.46$1.4314,300
$1.440.000.0%$1.46$1.46$1.4220,000
$1.440.000.0%$1.43$1.46$1.4318,700
$1.44+0.02+1.4%$1.42$1.45$1.4216,900
$1.42-0.06-4.1%$1.49$1.52$1.4225,400
$1.48-0.09-5.7%$1.57$1.58$1.4340,700
$1.57+0.04+2.6%$1.55$1.58$1.4887,127
$1.53+0.14+10.1%$1.39$1.54$1.39118,900
$1.39+0.02+1.5%$1.38$1.40$1.3726,000
$1.37-0.01-0.7%$1.38$1.38$1.3324,400
$1.38+0.04+3.0%$1.35$1.39$1.3556,000
$1.34+0.02+1.5%$1.33$1.35$1.3248,000
$1.32+0.01+0.8%$1.32$1.34$1.3067,400
$1.310.000.0%$1.32$1.33$1.3045,100
$1.31-0.02-1.5%$1.32$1.32$1.3122,200
$1.33+0.01+0.8%$1.32$1.33$1.3213,100
$1.320.000.0%$1.43$1.44$1.3217,700
$1.32-0.02-1.5%$1.42$1.42$1.3218,300
$1.34-0.02-1.5%$1.36$1.39$1.3411,400
$1.36+0.03+2.3%$1.37$1.39$1.3318,700
$1.33+0.03+2.3%$1.31$1.34$1.3113,800
$1.30-0.03-2.3%$1.33$1.34$1.3082,900
$1.330.000.0%$1.32$1.33$1.3139,200
$1.33-0.01-0.7%$1.35$1.35$1.338,000
$1.34+0.05+3.9%$1.29$1.35$1.2964,100
$1.29-0.04-3.0%$1.29$1.30$1.2817,300
$1.33+0.01+0.8%$1.38$1.38$1.3158,000
$1.320.000.0%$1.30$1.32$1.2917,900
$1.32+0.01+0.8%$1.30$1.33$1.3026,800
$1.31-0.02-1.5%$1.33$1.33$1.3033,800
$1.330.000.0%$1.33$1.33$1.3212,900
$1.33-0.01-0.7%$1.35$1.35$1.328,300
$1.34-0.01-0.7%$1.35$1.36$1.3329,200
Ticker
Tokyo:4875
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
Tokyo
Currency
JPY

What changed lately

Latest news

MediciNova CEO Provides Shareholder Update

Oct 12, 2026

Closed $1.54 (+1.3%) on Oct 12, 2026

MediciNova to Participate in the Maxim Growth Summit

Oct 6, 2026

Closed $1.65 (-6.3%) on Oct 6, 2026

MediciNova Announces Topline Results from MN-001-NATG-202 Clinical Trial of MN-001 (Tipelukast)

Sep 29, 2026

Closed $1.92 (-8.6%) on Sep 29, 2026

MediciNova Announces Completion of Last Patient, Last Visit in the Double-Blind Portion of the Phase 2b/3 COMBAT-ALS Trial of MN-166 (Ibudilast)

Sep 24, 2026

Closed $2.65 (-5.4%) on Sep 24, 2026

MediciNova to Participate in Two Investor Conferences in September

Sep 8, 2026

Closed $1.75 (+7.4%) on Sep 8, 2026

MediciNova Announces Patient Enrollment Milestone Achieved in SEANOBI Study Expanded-Access-Program Evaluating MN‑166 (ibudilast) in ALS patients

Jul 15, 2026

Closed $1.40 (+2.2%) on Jul 15, 2026

MediciNova Receives Notice of Allowance for New Patent Covering Use of MN-166 in Combination with Anti-PD-1 Immune Checkpoint Inhibitor for Glioblastoma Treatment

Jun 8, 2026

MediciNova Announces Completion of Last Patient Last Visit in the MN-001-NATG-202 Clinical Trial of MN-001 (Tipelukast)

May 26, 2026

New Peer‑Reviewed Study Reveals Actionable Immune–Microenvironment Target in Brain Metastasis; Medicinova Advances Clinical Translation

Apr 27, 2026

MediciNova to Participate at the 38th Annual ROTH Conference

Mar 16, 2026

All MediciNova, Inc. news

Decks

MediciNova, Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
21 in the last 12 months · 144 in all · newest Oct 12, 2026 · oldest 2019
Decks
32 decks · latest Sep 11, 2026

Where MediciNova, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:MNOV · Home listingNASDAQUnited StatesUSD
Tokyo:4875 メディシノバ・インク · This pageTokyoJapanJPY
BOATS:MNOVBOATSUnited StatesUSD

Log in to ask 6ix AI your own questions about MediciNova, Inc.